Drug Administration Routes
-
Subject Areas on Research
- A comprehensive outlook on intracerebral therapy of malignant gliomas.
- A peripheral cannabinoid mechanism suppresses spinal fos protein expression and pain behavior in a rat model of inflammation.
- A phase I trial of an antisense inhibitor of hepatitis C virus (ISIS 14803), administered to chronic hepatitis C patients.
- A randomized, placebo-controlled trial of enoxaparin after high-risk coronary stenting: the ATLAST trial.
- Adult emergency department patients with sickle cell pain crisis: a learning collaborative model to improve analgesic management.
- Alemtuzumab for the prevention and treatment of graft-versus-host disease.
- Antimicrobial stewardship programs: how to start and steer a successful program.
- Apomorphine in the treatment of Parkinson's disease.
- Association of Testosterone Levels With Anemia in Older Men: A Controlled Clinical Trial.
- CNS glucagon-like peptide-1 receptors mediate endocrine and anxiety responses to interoceptive and psychogenic stressors.
- Clinical variables associated with early administration of antipsychotics in bipolar mania.
- Comparison of intratumoral bolus injection and convection-enhanced delivery of radiolabeled antitenascin monoclonal antibodies.
- Comparison of the effect of intratesticular lidocaine/bupivacaine vs. saline placebo on pain scores and incision site reactions in dogs undergoing routine castration.
- Comparisons of characteristics and outcomes among women and men with acute myocardial infarction treated with thrombolytic therapy. GUSTO-I investigators.
- Critical shortage of new antibiotics in development against multidrug-resistant bacteria-Time to react is now.
- Development of a model of melphalan-induced gastrointestinal toxicity in mice.
- Dopamine transporter-dependent and -independent actions of trace amine beta-phenylethylamine.
- Effect of intracerebroventricular infusion of insulin on glucose-dependent insulinotropic peptide in dogs.
- Elevated mu-opioid receptor expression in the nucleus of the solitary tract accompanies attenuated withdrawal signs after chronic low dose naltrexone in opiate-dependent rats.
- Formation of complement membrane attack complex in mammalian cerebral cortex evokes seizures and neurodegeneration.
- Glucagon like peptide-1 accelerates colonic transit via central CRF and peripheral vagal pathways in conscious rats.
- Glutamine: mode of action in critical illness.
- Growth factors for therapeutic angiogenesis in peripheral arterial disease.
- IL-8 signaling does not mediate intra-amniotic LPS-induced inflammation and maturation in preterm fetal lamb lung.
- Informing the dosing of interventions in randomized trials.
- Large subretinal hemorrhage after intravitreal bevacizumab (Avastin) for age-related macular degeneration.
- Local knockdown of genes in the brain using small interfering RNA: a phenotypic comparison with knockout animals.
- Low-molecular-weight heparins in non-ST-segment elevation ischemia: the ESSENCE trial. Efficacy and Safety of Subcutaneous Enoxaparin versus intravenous unfractionated heparin, in non-Q-wave Coronary Events.
- Luteal supplementation in in vitro fertilization: more questions than answers.
- Monoclonal antibodies for brain tumour treatment.
- Multiagent induction and maintenance therapy for patients with refractory immune thrombocytopenic purpura (ITP).
- NTP-CERHR expert panel report on the reproductive and developmental toxicity of hydroxyurea.
- Novel modes of antifungal drug administration.
- Pain management in sickle cell disease. Rationale and techniques.
- Patient, Caregiver, and Nurse Preferences for Treatments for Bone Metastases from Solid Tumors.
- Pharmacologic studies in vulnerable populations: Using the pediatric experience.
- Pharmacological management of dyspnoea.
- Phase III randomized trial of CED of IL13-PE38QQR vs Gliadel wafers for recurrent glioblastoma.
- Predictors of recurrent ischemic events and death in unstable coronary artery disease after treatment with combination antithrombotic therapy.
- Rationale and study protocol for the Patient-Centered Outcome Aid (PCOA) randomized controlled trial: A personalized decision tool for newly diagnosed ovarian cancer patients.
- Recalcitrant rhinosinusitis, innate immunity, and mannose-binding lectin.
- Recombinant vaccine-induced protection against the highly pathogenic simian immunodeficiency virus SIV(mac251): dependence on route of challenge exposure.
- Regional squamous cell carcinomas following systemic sorafenib therapy and isolated limb infusion for regionally advanced metastatic melanoma of the limb.
- Route of immunization defines multiple mechanisms of vaccine-mediated protection against SIV.
- Skin and soft tissue infections in older adults.
- Spontaneous retinal activity is tonic and does not drive tectal activity during activity-dependent refinement in regeneration.
- Successful DNA immunization against measles: neutralizing antibody against either the hemagglutinin or fusion glycoprotein protects rhesus macaques without evidence of atypical measles.
- Therapy and clinical trials.
- Updated evidence on intracoronary abciximab in ST-elevation myocardial infarction: a systematic review and meta-analysis of randomized clinical trials.
-
Keywords of People
- Fekrat, Sharon, Professor of Ophthalmology, Ophthalmology, Vitreoretinal Diseases & Surgery
- Sampson, John Howard, Robert H., M.D. and Gloria Wilkins Professor of Neurosurgery, in the School of Medicine, Immunology
- Stinnett, Sandra Sue, Associate Professor of Biostatistics and Bioinformatics, Biostatistics & Bioinformatics